ProACT试验的实施策略是否足够积极主动？
Was the implementation strategy of the ProACT trial adequately proactive?
作者信息
Mathioudakis Alexander G, Vestbo Jørgen
机构信息
Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, University of Manchester, Manchester, UK.
出版信息
Breathe (Sheff). 2019 Mar;15(1):77-80. doi: 10.1183/20734735.0338-2018.
相似文献
1
Was the implementation strategy of the ProACT trial adequately proactive?ProACT试验的实施策略是否足够积极主动？
Breathe (Sheff). 2019 Mar;15(1):77-80. doi: 10.1183/20734735.0338-2018.
2
Procalcitonin as a biomarker of acute lower respiratory tract infections.降钙素原作为急性下呼吸道感染的生物标志物。
Expert Opin Med Diagn. 2009 Jan;3(1):67-79. doi: 10.1517/17530050802623859.
3
A Collaborative Approach to Improve Consistent Use of Procalcitonin in Lower Respiratory Tract Infections.协作方法改善下呼吸道感染中降钙素原的一致使用。
Ann Pharmacother. 2018 Jun;52(6):538-545. doi: 10.1177/1060028017753411. Epub 2018 Jan 11.
4
Procalcitonin-guided antibiotic therapy in patients with fever in a general emergency department population: a multicentre non-inferiority randomized clinical trial (HiTEMP study).降钙素原指导下的抗生素治疗在普通急诊患者发热中的应用：一项多中心非劣效性随机临床试验（HiTEMP 研究）。
Clin Microbiol Infect. 2018 Dec;24(12):1282-1289. doi: 10.1016/j.cmi.2018.05.011. Epub 2018 Jun 2.
5
Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.基于降钙素原的指南与标准指南对下呼吸道感染抗生素使用的影响：ProHOSP随机对照试验
JAMA. 2009 Sep 9;302(10):1059-66. doi: 10.1001/jama.2009.1297.
6
Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands.降钙素原检测指导危重症患者抗生素治疗时间的成本效益：荷兰一项随机对照多中心试验的结果。
Crit Care. 2018 Nov 13;22(1):293. doi: 10.1186/s13054-018-2234-3.
7
Cost-Effectiveness Analysis of a Procalcitonin-Guided Decision Algorithm for Antibiotic Stewardship Using Real-World U.S. Hospital Data.基于真实美国医院数据的降钙素原指导的抗生素管理决策算法的成本效果分析。
OMICS. 2019 Oct;23(10):508-515. doi: 10.1089/omi.2019.0113. Epub 2019 Sep 11.
8
Procalcitonin and lung ultrasonography point-of-care testing to decide on antibiotic prescription in patients with lower respiratory tract infection in primary care: protocol of a pragmatic cluster randomized trial.降钙素原和肺部超声即时检验用于指导基层医疗机构下呼吸道感染患者抗生素处方决策的实用性整群随机临床试验方案
BMC Pulm Med. 2019 Aug 6;19(1):143. doi: 10.1186/s12890-019-0898-3.
9
Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter poststudy survey (ProREAL).降钙素原指导的抗生素治疗在“现实生活”中用于下呼吸道感染的有效性和安全性：一项国际多中心研究后调查（ProREAL）
Arch Intern Med. 2012 May 14;172(9):715-22. doi: 10.1001/archinternmed.2012.770.
10
Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.降钙素原检测用于指导重症监护环境中脓毒症治疗及急诊科环境中疑似细菌感染治疗的抗生素疗法：一项系统评价与成本效益分析
Health Technol Assess. 2015 Nov;19(96):v-xxv, 1-236. doi: 10.3310/hta19960.
引用本文的文献
1
Using biomarkers to adjust corticosteroid dose in patients with severe asthma.使用生物标志物调整重度哮喘患者的皮质类固醇剂量。
Breathe (Sheff). 2021 Mar;17(1):200324. doi: 10.1183/20734735.0324-2020.
2
Procalcitonin in respiratory disease: use as a biomarker for diagnosis and guiding antibiotic therapy.降钙素原在呼吸系统疾病中的应用：作为诊断和指导抗生素治疗的生物标志物
Breathe (Sheff). 2019 Dec;15(4):296-304. doi: 10.1183/20734735.0258-2019.
3
Too much or too little medicine? Overdiagnosis, underdiagnosis, overtreatment and undertreatment in respiratory diseases.用药过多还是过少？呼吸系统疾病中的过度诊断、诊断不足、过度治疗和治疗不足
Breathe (Sheff). 2019 Mar;15(1):2-3. doi: 10.1183/20734735.0006-2019.
本文引用的文献
1
Adherence to a procalcitonin-guided antibiotic treatment protocol in patients with severe sepsis and septic shock.严重脓毒症和脓毒性休克患者对降钙素原指导的抗生素治疗方案的依从性。
Ann Intensive Care. 2018 Jun 4;8(1):68. doi: 10.1186/s13613-018-0415-5.
2
Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection.降钙素原指导下的下呼吸道感染抗生素使用
N Engl J Med. 2018 Jul 19;379(3):236-249. doi: 10.1056/NEJMoa1802670. Epub 2018 May 20.
3
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.降钙素原用于启动或停用急性呼吸道感染中的抗生素治疗。
Cochrane Database Syst Rev. 2017 Oct 12;10(10):CD007498. doi: 10.1002/14651858.CD007498.pub3.
4
Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis.降钙素原指导慢性阻塞性肺疾病急性加重期抗生素使用的荟萃分析
Eur Respir Rev. 2017 Jan 31;26(143). doi: 10.1183/16000617.0073-2016. Print 2017 Jan.
5
A mixed methods study to understand patient expectations for antibiotics for an upper respiratory tract infection.一项混合方法研究，旨在了解患者对上呼吸道感染使用抗生素的期望。
Antimicrob Resist Infect Control. 2016 Oct 20;5:39. doi: 10.1186/s13756-016-0134-3. eCollection 2016.
6
Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011.2010-2011 年美国门诊就诊中不适当抗生素处方的流行率。
JAMA. 2016 May 3;315(17):1864-73. doi: 10.1001/jama.2016.4151.
7
Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit.因慢性阻塞性肺疾病急性加重入院患者的抗生素处方：欧洲慢性阻塞性肺疾病审计
PLoS One. 2015 Apr 23;10(4):e0124374. doi: 10.1371/journal.pone.0124374. eCollection 2015.
8
Factors associated with antibiotic misuse in outpatient treatment for upper respiratory tract infections.上呼吸道感染门诊治疗中抗生素滥用的相关因素。
Antimicrob Agents Chemother. 2015 Jul;59(7):3848-52. doi: 10.1128/AAC.00652-15. Epub 2015 Apr 13.
9
Human rhinovirus infection during naturally occurring COPD exacerbations.人鼻病毒感染在自然发生的 COPD 加重期。
Eur Respir J. 2014 Jul;44(1):87-96. doi: 10.1183/09031936.00223113. Epub 2014 Mar 13.
10
Evaluation of a national programme to reduce inappropriate use of antibiotics for upper respiratory tract infections: effects on consumer awareness, beliefs, attitudes and behaviour in Australia.评估一项减少上呼吸道感染抗生素不当使用的国家计划：对澳大利亚消费者意识、观念、态度和行为的影响。
Health Promot Int. 2007 Mar;22(1):53-64. doi: 10.1093/heapro/dal034. Epub 2006 Oct 17.
Zotero 插件